Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Jan 1.

Published in final edited form as: Int J Drug Policy. 2015 Jun 9;27:113–120. doi: 10.1016/j.drugpo.2015.05.015

Table 4.

Feasibility of potential pharmacy-Delivered Services (No. (%))

	good idea to offer (PWID,n=403)	support offering (Pharmacy staff, n =50)	personally use this service if offered (PWID,n=403)	Possible to implement this service (Pharmacy staff, n=50)
HIV testing	317(78.7)	26(52.0)^**	308(76.4)	16(32.0)^**
Printed materials about HIV, Hepatitis C, and STDs risk reduction	384(95.3)	37(74.0)^**	381(94.5)	28(56.0)^**
Training or information about how to prevent abscesses	353(87.6)	38(76.0)^*	353(87.6)	26(52.0)^**
Training or information about how to inject safely	337(83.6)	19(38.0)^**	334(82.9)	10(20.0)^**
Training or information about preventing overdoses	350(86.8)	38(76.0)^*	347(86.1)	22(44.0)^**
Overdose medication (naloxone / narcan)	278(69)	13(26.0)^**	277(68.7)	6(12.0)^**
Free syringes	325(80.6)	2(4.0)^**	322(79.9)	1(2.0)^**
To dispose of used syringes	290(72)	13(26.0)^**	285(70.7)	11(22.0)^**

^*

p<0.05,

^**

<0.01 (χ² test)